After just over ten days, the popular demon-stock Zhongtong Bus once again announced a suspension for verification.
On the evening of June 21, Zhongtong Bus issued an announcement that due to the abnormal fluctuation of the company's stock recently, in order to protect the interests of investors, the company will check the abnormal fluctuation of stock trading. The company's shares have been suspended since the opening of the market on June 22 and resumed after the disclosure of the verification announcement.
The suspension is just over ten days after its last suspension verification from June 2 to June 9. After rubbing up on concepts such as nucleic acid testing vehicles and solar vehicles, Zhongtong Bus has started a violent pull-up mode since May 13. As of June 21, it has harvested 15 daily limit boards, with an interval increase of over 390%.
It should be pointed out that the nearly 4-fold surge of Zhongtong Bus has long deviated from the company's fundamentals. Affected by factors such as the epidemic, total industry volume, sales scale, rising costs, and rising expense ratios during the period, the company's non-net profit has been negative for three consecutive years; in addition, the company produced 439 vehicles in May, and this year's cumulative output was 2,580 vehicles, a year-on-year increase of 2,580 vehicles. Down 14.51%.
Shares have risen nearly 4 times
Recently, Zhongtong Bus, a popular auto stock, has attracted market attention due to the launch of nucleic acid detection vehicles and solar-powered extended-range intelligent driving buses, and its stock price has continued to soar. The data shows that from May 13th to May 31st, Zhongtong Bus achieved 13 daily limit plates in a row, and on June 17th and June 20th, Zhongtong Bus repeated the daily limit.
On June 22, Zhongtong Bus closed up slightly by 2.11%, and the stock once soared to 21.49 yuan per share during the session, hitting a new high for the year. As of the close, Zhongtong Bus reported 21.32 yuan. Its stock price has risen by more than 390% since May 13, an increase of nearly 4 times, and the latest market value is 12.6 billion yuan.
Since the stock trading price has accumulated more than 20% deviation from the closing price within 3 consecutive trading days (June 17, 2022, June 20, 2022, and June 21, 2022), according to the "Shenzhen Stock Exchange Trading Rules" The relevant provisions of the stock exchange are subject to abnormal fluctuations in stock trading. Zhongtong Bus announced that it will conduct inspections on abnormal fluctuations in stock transactions. The stock will be suspended from the market opening on June 22, 2022, reminding investors to pay attention to the risks of secondary market transactions.
On the news, on May 6, Zhongtong Bus issued a press release on its official website saying that during the May Day holiday, the company delivered 18 nucleic acid testing vehicles at one time to help prevent and control the epidemic across the country. It is reported that the company's products currently sold in batches include two nucleic acid detection vehicles of 12 meters and 13 meters, all of which meet the P2+ biosafety laboratory standard, equipped with medical-specific air conditioning systems, equipped with high-efficiency fresh air filtration systems, medical water supply and drainage systems, fully automatic PCR analysis system, 5G signal transmission, etc., have the functions of on-demand sampling, on-demand inspection, and on-demand reporting.
In addition, on the evening of June 17, Zhongtong Bus also disclosed an announcement on the record form of investor relations activities. The company has completed the research and development of solar-powered extended-range intelligent driving buses, which have the functions of solar power generation and automatic driving, and can realize solar energy access. Power Battery.
Who is hyping up Zhongtong Bus?
Sitting on the two popular concepts of nucleic acid detection vehicles and new energy vehicles, there are obvious signs of hot money driving up behind the skyrocketing share price of Zhongtong Bus.
For example, on June 21, Zhongtong Bus was listed on the Dragon and Tiger List due to a cumulative increase of 20% in three consecutive trading days. Judging from the trading data released by the Dragon and Tiger List on the same day, the well-known hot money seat "Lhasa Legion" (Oriental Fortune Securities Lhasa Tuanjie Road No. 1 Business Department, Orient Fortune Securities Lhasa East Ring Road No. 1 and Second Business Department, etc.), Ningbo Sangtian Road, etc. are on the list.
For another example, during the period of 13 consecutive daily trading limits for its stock price from May 13 to May 31, Zhongtong Bus also frequently appeared on the Shanghai-Shenzhen Long-Tiger List, Galaxy Securities Shaoxing Securities Sales Department, Huaxin Securities Jiangsu Branch, Ping An Securities Hangzhou Hangda Road Sales Department and many other seats that are frequented by hot money frequently make the list.
It is worth mentioning that the most benefited from the skyrocketing share price of Zhongtong Bus is Shenzhen Qixing Asset Management Co., Ltd. (hereinafter referred to as "Qixing Assets") and its three private equity funds.
WIND data shows that Qixing Assets has become the fifth largest shareholder of Zhongtong Bus since the third quarterly report of 2020, and its three private equity products have followed closely. With the addition of positions, as of the first quarter of 2022, Qixing Assets and the three private equity products it manages held a total of 15.4079 million shares.
If the closing price of Zhongtong Bus in the fourth quarter of 2020 is 8.73 yuan, as of the close of June 21 this year, the share price of Zhongtong Bus will be at 21.32 yuan per share. If Qixing Assets and its private equity products have been held until now, floating profit will reach more than 140%.
It is worth noting that Shandong State-owned Assets Investment Holdings Co., Ltd. (hereinafter referred to as "Shandong SDIC"), the second largest shareholder of Zhongtong Bus, has recently developed the idea of being safe.
On the evening of May 31, Zhongtong Bus disclosed that Shandong SDIC plans to reduce its holdings of Zhongtong Bus by no more than 11.8 million shares within 15 trading days from the date of the announcement of the reduction plan, accounting for 6 months. 1.9902% of the total share capital of the listed company. Up to now, Shandong SDIC holds a total of 112 million shares of Zhongtong Bus, accounting for 18.96% of the total share capital of Zhongtong Bus.
Net profit declines year by year or even loses
In fact, the skyrocketing share price of Zhongtong Bus has already attracted regulatory attention. The suspension of trading has only passed for more than ten days since its last suspension verification from June 2 to June 9.
As early as the evening of May 27, the Shenzhen Stock Exchange issued a letter of concern to Zhongtong Bus, requiring the company to combine the production of nucleic acid testing vehicles, the amount of revenue, and the status of orders in hand, etc., to explain the company's nucleic acid testing vehicle business. etc. influence.
However, the conclusion is that only 38 nucleic acid detection vehicles of Zhongtong Bus have been sold. On May 31, Zhongtong Bus responded to the Shenzhen Stock Exchange's letter of concern, stating that there has been no abnormality in the company recently. From January to April, the company sold a total of 20 nucleic acid detection vehicles, with a revenue of 61.7097 million, and the revenue of this product accounted for 5.39% of the company's operating revenue; production was determined based on sales, and there was no inventory. As of May 30, the company had orders for 18 nucleic acid testing vehicles in hand, with an estimated revenue of 45.78 million yuan. The nucleic acid detection vehicle business is insufficient to have a significant impact on the company's business development and profitability.
In response to the above reply, the regulator once again asked it to suspend trading for verification from June 2 and issue an inquiry letter at the same time. On the evening of June 13, Zhongtong Bus responded to the inquiry letter from the Shenzhen Stock Exchange. Zhongtong Bus stated that due to the comprehensive impact of factors such as the epidemic, total industry volume, sales scale, rising costs, and rising expense ratios during the period, the company's net profit and profitability after non-deductions have declined year by year.
Specifically, in 2019, 2020 and 2021, the company achieved operating income of 6.741 billion yuan, 4.408 billion yuan and 4.587 billion yuan, net profit of 33 million yuan, 24 million yuan and -220 million yuan, and realized the deduction of non- Net profit from recurring gains and losses was -79 million yuan, -227 million yuan and -276 million yuan.
As for the reasons for the continuous decline in performance and even losses, Zhongtong Bus explained that while the sales of passenger cars continued to decline, the cost of each vehicle was also rising. The data shows that the company's sales from 2019 to 2021 were 15,038 units, 10,466 units and 10,050 units respectively, and the sales volume in the past three years has shown a downward trend year by year.
According to the 2022 first quarter report of Zhongtong Bus, the company's main income was 863 million yuan, up 30.93% year-on-year; net profit attributable to the parent was -35.287 million yuan, up 11.12% year-on-year; non-net profit deducted -42.4648 million yuan, up 38.31% year-on-year; liabilities The profit rate is 73.35%, the investment income is -809,800 yuan, the financial cost is 15,513,600 yuan, and the gross profit rate is 13.1%.
During the suspension inspection period, Zhongtong Bus announced its May and annual production and sales data. According to the data, the company produced 439 vehicles in May, and the cumulative output this year was 2,580 vehicles, a year-on-year decrease of 14.51%. In May, 482 vehicles were sold, and the cumulative sales this year were 2,739 vehicles, a year-on-year decrease of 7.72%.
As for whether the nucleic acid detection vehicle can save the company's performance, another major domestic bus leader, Yutong Bus, stated on the investor interaction platform in March this year that the nucleic acid detection vehicle is a special vehicle product launched by the company according to market demand, and it belongs to a segmented product model. The sales volume accounts for a small proportion of the company's total sales and will not have a major impact on the company's performance.
Original title: "15 Board Demon Stocks" Suspended Again for Verification! The performance has been losing money year after year, but the stock price has skyrocketed 4 times. Who is hyping it?
